Filing Details

Accession Number:
0001213900-23-089692
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-22 18:51:43
Reporting Period:
2023-11-21
Accepted Time:
2023-11-22 18:51:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641281 Bolt Biotherapeutics Inc. BOLT () 1231
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1618788 Vivo Capital Fund Viii, L.p. 192 Lytton Avenue
Palo Alto, CA 94301
No No Yes No
1618789 Vivo Capital Viii, Llc 192 Lytton Avenue
Palo Alto, CA 94301
No No Yes No
1628048 Vivo Capital Surplus Fund Viii, L.p. 192 Lytton Avenue
Palo Alto, CA 94301
No No Yes No
1675490 Vivo Panda Fund, L.p. 192 Lytton Avenue
Palo Alto, CA 94301
No No Yes No
1728970 Vivo Opportunity, Llc 192 Lytton Avenue
Palo Alto, CA 94301
No No Yes No
1843847 Vivo Panda, Llc 192 Lytton Avenue
Palo Alto, CA 94301
No No Yes No
1930214 Vivo Opportunity Fund Holdings, L.p. 192 Lytton Avenue
Palo Alto, CA 94301
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-21 1,707 $0.90 1,952,302 No 4 S Indirect By: Vivo Capital Fund VIII, L.P.
Common Stock Disposition 2023-11-21 236 $0.90 269,587 No 4 S Indirect By: Vivo Capital Surplus Fund VIII, L.P.
Common Stock Disposition 2023-11-21 1,457 $0.90 111,662 No 4 S Indirect By: Vivo Opportunity Fund Holdings, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By: Vivo Capital Fund VIII, L.P.
No 4 S Indirect By: Vivo Capital Surplus Fund VIII, L.P.
No 4 S Indirect By: Vivo Opportunity Fund Holdings, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,448,286 Indirect By: Vivo Panda Fund, L.P.
Footnotes
  1. The shares are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the General Partner of Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
  2. The shares are held of record by Vivo Capital Surplus Fund VIII, L.P. Capital VIII, LLC is the General Partner of Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
  3. The shares are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the General Partner of Vivo Opportunity Holdings, L.P. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
  4. The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.90 to $0.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4.